Barclays backs biotech with fresh calls on oncology and immunology stocks
PositiveFinancial Markets

Barclays has shown strong support for the biotech sector, particularly in oncology and immunology, by making fresh calls on related stocks. This move is significant as it highlights the growing confidence in biotech innovations that could lead to breakthroughs in cancer treatment and immune therapies. Investors are likely to pay close attention to these recommendations, as they could signal promising opportunities in a rapidly evolving market.
— Curated by the World Pulse Now AI Editorial System